Study of GZR18 effects on metformin in overweight adults
Part of Hormones & metabolism clinical trials.
This study tests if an investigational medication, GZR18 (given as an injection), affects how the body handles metformin (a common diabetes medicine). It is for overweight or obese adults. The goal is to help researchers understand if the two medicines can be used together safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- Your weight is at least 110 lbs (50 kg).
- Your body mass index (BMI) is between 24 and 33.
- You are Chinese and currently live in China.
- You are willing to use birth control if you could become pregnant or get someone pregnant.
- You have no major health conditions (heart, liver, kidney, stomach, etc.) and no recent surgeries or infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.
This trial tests how a new injectable drug, GZR18, affects how fast your stomach empties and how it interacts with other medicines. It is for obese Chinese adults who want to join a research study.
This study tests whether a change in the manufacturing process for GZR18 (an experimental injectable drug) affects how it works in the body. It may help determine if the new version is as safe and effective as the original.
This trial tests how a new drug called GZR18 (given as an injection) affects the body in people with different levels of kidney function. It aims to find the right dose and check for side effects, which could help guide treatment for people with kidney issues.
This study tests how a new diabetes medicine called ZT002 works in the body and whether it interacts safely with other common medications. Researchers will monitor healthy volunteers who are overweight to understand the medicine's safety and effectiveness.
This study tests a new drug called GZR18 to see how it works in people with different levels of liver function. It aims to help find the right dose and check safety.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.